MAKE A MEME
View Large Image
| View Original: | cahalan_p081020_01_daa_copy.jpg.jpg (1024x683) | |||
| Download: | Original | Medium | Small | Thumb |
| Courtesy of: | www.flickr.com | More Like This | ||
| Keywords: autoimmunity daniel a. anderson (daa) danielaandersondaa immunology melanie matheu melaniematheu michael cahalan michaelcahalan professor student irvine california usa people FINAL CAPTION: Disease-mediating T cells during an inflammatory response in the skin (left) are kept small, immobile and unactivated (right) by treatment with a drug developed at UC Irvine, giving new hope for autoimmune and inflammatory disease treatment. Immunology researcher Michael Cahalan, right, and graduate student researcher Melanie Matheu are authors of the study. FEATURES CAPTION: The immune system is the body's military forces, assigned to protect against disease and infection. But sometimes, the T cells and B cells that carr out this vital mission turn against their host and mistakenly attack healthy tissue in a process called autoimmunity. GENERIC CAPTION: Disease mediating T cells during an inflammatory response in the skin (left) are kept small, immobile and unactivated (right) by treatment with a drug developed here at UC Irvine, giving new hope for autoimmune and inflammatory disease treatment. FINAL CAPTION: Disease-mediating T cells during an inflammatory response in the skin (left) are kept small, immobile and unactivated (right) by treatment with a drug developed at UC Irvine, giving new hope for autoimmune and inflammatory disease treatment. Immunology researcher Michael Cahalan, right, and graduate student researcher Melanie Matheu are authors of the study. FEATURES CAPTION: The immune system is the body's military forces, assigned to protect against disease and infection. But sometimes, the T cells and B cells that carr out this vital mission turn against their host and mistakenly attack healthy tissue in a process called autoimmunity. GENERIC CAPTION: Disease mediating T cells during an inflammatory response in the skin (left) are kept small, immobile and unactivated (right) by treatment with a drug developed here at UC Irvine, giving new hope for autoimmune and inflammatory disease treatment. | ||||
